Associated Papers
Influences of cytochrome b5 expression and its genetic variant on the activity of CYP2C9, CYP2C19 and CYP3A4.
Yoo SE et al.
Drug Metabolism and Pharmacokinetics, 2019
Individual variability in the detoxification of carcinogenic arylhydroxylamines in human breast.
Rhoads K et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology, 2011
Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction.
Sacco JC et al.
Pharmacogenetics and Genomics, 2010
Select a paper to view details